← 產業報告目錄

Lutetium-177 Market Size, Share & Trends Analysis Distribution by Application (Oncology, Non-Oncology), Type (No-Carrier-Added (NCA) Lu-177, Carrier-Added (CA) Lu-177), Product Type (Approved Drugs, Pipeline Drugs, Investigational Drugs), Scale of Operation (Preclinical, Clinical, Commercial), End-user (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Research Institutions/CROs), Production(Reactor-Based, Cyclotron-Based), Technology (Targeting Ligands, Production Innovations, Combination Therapies) and Segment Forecasts, 2025-2034

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-03頁數 180報告編號 INSIGHTACE-fc253beeba

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

With a 2024 valuation of USD 2.11 Bn, the global Lutetium-177 Market is set to accelerate to USD 7.41 Bn by 2034, demonstrating a CAGR of 11.6% during the 2025–2034 forecast window. Lutetium-177 covers a radioactive isotope employed in targeted radionuclide therapy for neuroendocrine tumors and prostate cancer. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space. Several factors contribute to this trajectory, including heightened interest in next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives. Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential. Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases. Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing. Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Lutetium-177 Market Snapshot Chapter 4. Global Lutetium-177 Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Porter's Five Forces Analysis 4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031 4.8. Global Lutetium-177 Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031 4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023) 4.10. Use/impact of AI on Radiopharma Industry Trends Chapter 5. Lutetium-177 Market Segmentation 1: By Application, Estimates & Trend Analysis 5.1. Market Share by Application, 2023 & 2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Application: 5.2.1. Oncology 5.2.1.1. mCRPC 5.2.1.2. NETs 5.2.1.3. RCC 5.2.1.4. Other Cancers 5.2.2. Non-Oncology 5.2.2.1. Arthritis 5.2.2.2. Other Chapter 6. Lutetium-177 Market Segmentation 2: By Type, Estimates & Trend Analysis 6.1. Market Share by Type, 2023 & 2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Type: 6.2.1. Carrier-Added Lutetium-177 6.2.2. No-Carrier-Added Lutetium-177 Chapter 7. Lutetium-177 Market Segmentation 3: By Product Type, Estimates & Trend Analysis 7.1. Market Share by Product Type 2023 & 2034 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Product Type: 7.2.1. Approved Drugs 7.2.1.1. Pluvicto (Pro) 7.2.1.2. Lutathera (Pro) 7.2.2. Pipeline Drugs 7.2.3. Investigational Drug Chapter 8. Lutetium-177 Market Segmentation 4: By Scale of Operation, Estimates & Trend Analysis 8.1. Market Share by Scale of Operation, 2023 & 2034 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Scale of Operation: 8.2.1. Preclinical 8.2.2. Clinical 8.2.3. Commercial Chapter 9. Lutetium-177 Market Segmentation 5: By End-user, Estimates & Trend Analysis 9.1. Market Share by End-user, 2023 & 2034 9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following End-user: 9.2.1. Hospitals & Clinics 9.2.2. Pharmaceutical & Biotechnology Companies 9.2.3. Research Institutions/CROs Chapter 10. Lutetium-177 Market Segmentation 6: By Production, Estimates & Trend Analysis 10.1. Market Share by Production, 2023 & 2034 10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Production: 10.2.1. Reactor-Based 10.2.2. Cyclotron-Based Chapter 11. Lutetium-177 Market Segmentation 7: By Technology, Estimates & Trend Analysis 11.1. Market Share by Technology, 2023 & 2034 11.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Technology: 11.2.1. Targeting Ligands 11.2.2. Production Innovations 11.2.3. Combination Therapies Chapter 12. Lutetium-177 Market Segmentation 8: Regional Estimates & Trend Analysis 12.1. Global Lutetium-177 Market, Regional Snapshot 2023 & 2034 12.2. North America 12.2.1. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 12.2.1.1. US 12.2.1.2. Canada 12.2.2. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 12.2.3. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034 12.2.4. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Product Type 2021-2034 12.2.5. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034 12.2.6. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 12.2.7. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Production, 2021-2034 12.2.8. North America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034 12.3. Europe 12.3.1. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 12.3.1.1. Denmark 12.3.1.2. Finland 12.3.1.3. Austria 12.3.1.4. France 12.3.1.5. Germany 12.3.1.6. Israel 12.3.1.7. Italy 12.3.1.8. Netherlands 12.3.1.9. Norway 12.3.1.10. Poland 12.3.2. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 12.3.3. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034 12.3.4. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Product Type 2021-2034 12.3.5. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034 12.3.6. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 12.3.7. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Production, 2021-2034 12.3.8. Europe Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts Technology, 2021-2034 12.4. Asia Pacific 12.4.1. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 12.4.1.1. Australia 12.4.1.2. China 12.4.1.3. India 12.4.1.4. Indonesia 12.4.1.5. Japan 12.4.1.6. Malaysia 12.4.1.7. Philippines 12.4.1.8. Singapore 12.4.1.9. South Korea 12.4.1.10. Taiwan 12.4.1.11. Thailand 12.4.1.12. Rest of APAC 12.4.2. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 12.4.3. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034 12.4.4. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts By Product Type 2021-2034 12.4.5. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034 12.4.6. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 12.4.7. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Production, 2021-2034 12.4.8. Asia Pacific Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034 12.5. Latin America 12.5.1. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 12.5.1.1. Argentina 12.5.1.2. Brazil 12.5.1.3. Mexico 12.5.1.4. Rest of LATAM 12.5.2. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 12.5.3. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034 12.5.4. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Product Type 2021-2034 12.5.5. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034 12.5.6. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 12.5.7. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Production, 2021-2034 12.5.8. Latin America Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034 12.6. Middle East & Africa 12.6.1. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 12.6.1.1. Egypt 12.6.1.2. Israel 12.6.1.3. Nigeria 12.6.1.4. Saudi Arabia 12.6.1.5. Qatar 12.6.1.6. United Arab Emirates 12.6.1.7. Rest of MEA 12.6.2. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 12.6.3. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034 12.6.4. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Product Type 2021-2034 12.6.5. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034 12.6.6. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 12.6.7. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Production, 2021-2034 12.6.8. Middle East & Africa Lutetium-177 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034 Chapter 13. Competitive Landscape 13.1. Major Mergers and Acquisitions/Strategic Alliances 13.2. Company Profiles 13.2.1. Novartis AG 13.2.1.1. Business Overview 13.2.1.2. Key Product/Service 13.2.1.3. Financial Performance 13.2.1.4. Modeance 13.2.1.5. Geographical Presence 13.2.1.6. Recent Developments with Business Strategy 13.2.2. Curium 13.2.3. Telix Pharmaceuticals 13.2.4. ITM Isotope Technologies 13.2.5. Eli Lilly (via POINT Biopharma) 13.2.6. Radiopharm Theranostics 13.2.7. Advanced Accelerator Applications (AAA) 13.2.8. Evergreen Theragnostics 13.2.9. Nusano Inc. 13.2.10. Nordic Nanovector

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們